Topical 3% diclofenac in 2.5% hyaluronan gel for the treatment of actinic keratoses
Rivers, J.K.
Skin Therapy Letter 9(1): 1-3
2004
ISSN/ISBN: 1201-5989 PMID: 14716439 Document Number: 583288
Actinic Keratoses (AKs) are epidermal skin lesions that have the potential to develop into squamous cell carcinoma. Many of the treatment options available can cause discomfort, pain or skin irritation. Topical 3% diclofenac in 2.5% hyaluronan gel (Solaraze, Bioglan Pharma) is a relatively new treatment that has been shown to be effective and well tolerated for the treatment of AKs.
Document emailed within 1 workday
Related Documents
Javor, S.; Cozzani, E.; Parodi, A. 2016: Topical treatment of actinic keratosis with 3.0% diclofenac in 2.5% hyaluronan gel: review of the literature about the cumulative evidence of its efficacy and safety Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 151(3): 275-280Berlin, J.M.; Rigel, D.S. 2008: Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery Journal of Drugs in Dermatology: Jdd 7(7): 669-673
Smith, S.R.; Morhenn, V.B.; Piacquadio, D.J. 2006: Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp Journal of Drugs in Dermatology: Jdd 5(2): 156-159
Seckin, D.; Cerman, A.Aksu.; Yildiz, A.; Ergun, T. 2009: Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report Journal of drugs in dermatology: JDD 8(5): 451-454
Resnick, L.; Rabinovitz, H.; Binninger, D.; Marchetti, M.; Weissbach, H. 2009: Topical sulindac combined with hydrogen peroxide in the treatment of actinic keratoses Journal of Drugs in Dermatology: Jdd 8(1): 29-32
Strohal, R.; Kerl, H.; Schuster, L. 2012: Treatment of actinic keratoses with 5% topical imiquimod: a multicenter prospective observational study from 93 Austrian office-based dermatologists Journal of Drugs in Dermatology: Jdd 11(5): 574-578
Nelson, C.; Rigel, D.; Smith, S.; Swanson, N.; Wolf, J. 2004: Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze) Journal of Drugs in Dermatology: Jdd 3(4): 401-407
Simmonds, W.L. 1976: Management of actinic keratoses with topical 5-fluorouracil Cutis 18(2): 298-300
Tutrone, W.D.; Saini, R.; Caglar, S.; Weinberg, J.M.; Crespo, J. 2003: Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod Cutis 71(5): 365-370
del Rosso, J.Q. 2003: An update on newer topical therapies for actinic keratoses: advances and applications Journal of Drugs in Dermatology: Jdd 2(1): 35-39
Stoddard, M.; Herrmann, J.; Moy, L.; Moy, R. 2017: Improvement of Actinic Keratoses Using Topical DNA Repair Enzymes: a Randomized Placebo-Controlled Trial Journal of Drugs in Dermatology: Jdd 16(10): 1030-1034
Schmieder, G.J.; Huang, E.Y.; Jarratt, M. 2012: A multicenter, randomized, vehicle-controlled phase 2 study of blue light photodynamic therapy with aminolevulinic acid HCl 20% topical solution for the treatment of actinic keratoses on the upper extremities: the effect of occlusion during the drug incubation period Journal of Drugs in Dermatology: Jdd 11(12): 1483-1489
Gold, M.H. 2008: Pharmacoeconomic analysis of the treatment of multiple actinic keratoses Journal of Drugs in Dermatology: Jdd 7(1): 23-25
Price, N.M. 2007: The treatment of actinic keratoses with a combination of 5-fluorouracil and imiquimod creams Journal of Drugs in Dermatology: Jdd 6(8): 778-781
Lundin, A.; Berne, B.; Michaëlsson, G. 1992: Topical retinoic acid treatment of photoaged skin: its effects on hyaluronan distribution in epidermis and on hyaluronan and retinoic acid in suction blister fluid Acta Dermato-Venereologica 72(6): 423-427
Gilbert, D.J. 2005: Treatment of actinic keratoses with sequential combination of 5-fluorouracil and photodynamic therapy Journal of Drugs in Dermatology: Jdd 4(2): 161-163
Shaffelburg, M. 2009: Treatment of actinic keratoses with sequential use of photodynamic therapy; and imiquimod 5% cream Journal of Drugs in Dermatology: Jdd 8(1): 35-39
Bissonette, R.; Bergeron, A.; Liu, Y. 2004: Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond Journal of Drugs in Dermatology: Jdd 3(1 Suppl): S26-S31
Iglesias-Puzas, A.; Batalla, A.; Suh-Oh, H.J.; Flórez, A. 2019: 0.5% 5-Fluorouracil/10% Salicylic Acid for the Treatment of Distal Actinic Keratoses Under Daily Practice Conditions Journal of Drugs in Dermatology: Jdd 18(3): 285-288
Vergilis-Kalner, I.J.; Cohen, J.L. 2013: The use of photodynamic therapy as chemoprevention for the treatment of actinic keratoses and reduction in the number of non-melanoma skin cancers Journal of Drugs in Dermatology: Jdd 12(10): 1085-1086